Company
Headquarters: Beijing, China
Employees: 5,270
CN¥4.55 Billion
CNY as of Jan. 1, 2026
US$649.1 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, APIs, and pharmaceutical packaging materials in China and internationally. The company provides products for pediatrics, female healthcare, cardiovascular, big health, and elderly chronic diseases under the Diarrago, Baiyu, and Yabao brands. It also offers plastic bottles and cartons. The company provides its products in the form of injections, tablets, capsules, granules, pills, patches, freeze-dried powders, mixtures, suppositories, and solutions. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Yuncheng, China.
Yabao Pharmaceutical Group Co. Ltd has the following listings and related stock indices.
Stock: SSE: 600351